Skip to content
Search

Latest Stories

AIMp urges further discussions over off-payroll working rules

The Association of Independent Multiple Pharmacies (AIMp) today expressed concern over the implementation of new off-payroll working rules.

The association has urged the treasury to engage with the pharma sector for further discussions on the issue.


In a letter to HM Treasury, AIMp chief executive Leyla Hannbeck said the implementation of new off-payroll working rules may impact seriously on the services pharmacies provide to people.

“We are concerned that the introduction of these new rules will have a deep impact on our members ability to maintain consistent pharmaceutical services in local communities. We fear that these new rules may impact seriously on healthcare provision to the 1.6 million people who visit pharmacy in England each day, 1.2 million of them for health-related reasons," Hannbeck wrote.

"Many of these visitors are the more vulnerable people in society who rely on the services that community pharmacies provide to them, without the need for appointments."

She warned that any shortage of locum pharmacists will certainly cause unplanned closure of pharmacies.

“As we all know, a pharmacy can only legally function if it has a qualified pharmacist on the premises. A pharmacy can only provide certain services if the pharmacist is formally trained in them,” she said.

“Locum pharmacists are an integral part of the pharmaceutical workforce, used both planned and unplanned to cover holidays, days off, sickness and many other absences. They have a variety of training and skills which are not common to everyone, such as; flu vaccination training, CPCS service provision, etc. The ability to select individuals at both long and short notice, from a resource group, with specific training and experience for a specific gap that needs filling is critical.”

Hannbeck further outlined the association’s concerns over the introduction and use of the CEST tool which is not 'fit for purpose'. The letter called for the treasury to engage with the sector to further discuss how the IR35 off-payroll working rules need to be revised.

“It is vital, that community pharmacy and especially UK based independent pharmacy businesses voices are heard at the highest level as this new tax rule will have a huge implication on all of our members business models, who rely on locum pharmacists throughout the year.

"It’s all very well implementing new taxation tools but they have to be fit for purpose and there needs to be a realisation that this new rule may well have a far-reaching consequences, that go beyond the financial implications,” the AIMp chief added.

The government has announced changes to the draft off-payroll working (IR35) rules last week, which are due to apply to private and third sector engagements from April 6, 2020.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less